View Older Stories View More Recent Stories

Nov 11, 2015 07:19AM Hackett Group, Inc. (HCKT) Shows Strength in North America; Roth Capital Raises Price Target to $18
Nov 11, 2015 06:49AM Canadian Solar (CSIQ) Capacity Expansion Continues Accelerating; Roth Affirms at 'Buy'
Nov 10, 2015 09:18AM Roth Trims PT on Galena (GALE) Following Q3 Results, Plans to Spin Commercial Assets
Nov 10, 2015 07:39AM Roth Capital Cuts Price Target on Exar Corp. (EXAR) Following In-Line 2Q Results
Nov 9, 2015 02:54PM Curis (CRIS) Outpaces in Q3; Roth Affirms 'Buy' Rating Ahead of ASH
Nov 9, 2015 02:20PM TG Therapeutics' (TGTX) Q3 Results Solid; Roth Remains Positive into ASH Conference
Nov 9, 2015 09:00AM ROTH Capital Partners Honored by Global M&A Network
Nov 9, 2015 08:40AM Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 3Q15
Nov 9, 2015 07:32AM Cytokinetics (CYTK) and Amgen Inc. (AMGN) Announce COSMIC-HF Data; Roth Capital Raises Price Target to $22
Nov 9, 2015 07:00AM RedHill Biopharma Reports Results for the Third Quarter of 2015
Nov 6, 2015 09:41AM First Data from Rexahn's (RNN) Archexin Phase 2a Release; Appears Right on Track - Roth
Nov 6, 2015 09:13AM Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
Nov 6, 2015 09:05AM Pixelworks to Participate at ROTH Technology Corporate Access Day on November 18
Nov 6, 2015 09:00AM Adesto Technologies to Participate at ROTH New York Technology Corporate Access Day on November 18
Nov 6, 2015 08:37AM Skullcandy's (SKUL) Higher-Than-Expected Gross Margin Offset Low Revenue; Roth Capital Reiterates Buy
Nov 6, 2015 08:17AM Sarepta (SRPT) Conditional-Approval Thesis Unchanged, Roth Capital Says
Nov 6, 2015 08:11AM Roth Capital Starts Dimension Therapeutics (DMTX) at Buy
Nov 6, 2015 08:10AM Roth Capital Downgrades Constant Contact (CTCT) to Sell Amid Pending Takeover
Nov 5, 2015 04:30PM Intec Pharma Reports Results for the Third Quarter of 2015
Nov 5, 2015 01:27PM bluebird bio (BLUE) LentiGlobin is Here To Stay, Roth Capital Says; PT Cut to $165
Nov 5, 2015 12:19PM Streetinsider.com's Hot Lunchtime Reads 11/5: (VRX) (CAB) (QCOM) (BLRX) (RNWK)
Nov 5, 2015 11:51AM BioLineRx's (BLRX) Latest BL-8040 Phase 2 Data in r/r AML is 'Intriguing' - Roth Capital
Nov 5, 2015 09:32AM Pre-Open Stock Movers 11/05: (AWAY) (SD) (FB) Higher; (XENT) (LCI) (BLUE) Lower (more...)
Nov 5, 2015 08:17AM Roth Capital Downgrades Energy Focus (EFOI) to Neutral
Nov 5, 2015 07:43AM Roth Capital Downgrades Sapiens International Corp. NV (SPNS) to Neutral
Nov 5, 2015 07:24AM Roth Capital Upgrades Cogentix Medical (CGNT) to Buy
Nov 4, 2015 11:00AM Gerhard Erdelji Joins HomeStreet to Lead Investor Relations
Nov 4, 2015 09:48AM Roth Capital Raises Price Target on MaxLinear (MXL) Following 3Q Results
Nov 4, 2015 09:38AM Same-Store Sales Remain Strong; Roth Capital Remains Neutral on Denny's Corp (DENN)
Nov 4, 2015 09:00AM ROTH Capital Partners to Host Technology Corporate Access Day in New York City, NY on November 18th, 2015
Nov 4, 2015 08:42AM Top Image Systems to Participate in the ROTH Technology Corporate Access Day in New York
Nov 4, 2015 08:18AM Better Than Anticipated Cash Costs Drive EPS Beat for Coeur Mining (CDE); Roth Capital Reiterates Buy
Nov 4, 2015 08:13AM Non-Core Brands Downside Contribute to ANI Pharma's (ANIP) Revenue Miss; Roth Capital Reiterates Buy
Nov 4, 2015 06:43AM MeetMe (MEET) PT Bumped to $4.25 at Roth Capital Post Q3
Nov 4, 2015 06:40AM Roth Capital Downgrades Enphase Energy (ENPH) to Neutral
Nov 3, 2015 11:49AM Roth Affirms Rexahn Pharma (RNN) at 'Buy'; Broad POC Program Initiation, Archexin Data in mRCC on Tap
Nov 3, 2015 09:26AM VBL Therapeutics (VBLT) Prices $15M Offering of Ordinary Shares and Warrants
Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
Nov 3, 2015 09:21AM Vascular Biogenics Ltd. Announces Pricing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
Nov 3, 2015 07:09AM Roth Capital Cuts Price Target on Constant Contact (CTCT) Following Announced Acquisition by Endurance International Group (EIGI)
Nov 2, 2015 03:25PM Notable 52-Week Highs and Lows 11/2:(MGM) (GT) (NEO) High; (EIGI) (TKAI) (ENPH) Low
Nov 2, 2015 08:20AM Roth Capital Expects In-Line Results From SolarEdge Technologies (SEDG) 1Q16
Nov 2, 2015 08:01AM Roth Capital Cuts Price Target on Enphase Energy (ENPH) Ahead of 3Q Earnings Report
Nov 2, 2015 07:52AM Escalade (ESCA) Reports 3Q EPS Miss; Roth Capital Reiterates Buy
Oct 30, 2015 08:32AM Exact Sciences (EXAS) Releases Light 4Q Guidance; Roth Capital Cuts Price Target to $12
Oct 30, 2015 08:08AM SolarCity's (SCTY) Kitchen Sink Quarter – Roth Capital
Oct 29, 2015 12:59PM Roth Capital Upgrades GP Strategies (GPX) to Buy
Oct 29, 2015 11:47AM OCTANe Set to Host 10th Annual Medical Device & Investor Forum
Oct 29, 2015 11:17AM Notable Analyst Rating Changes 10/29: (LNCE) (MPEL) (PEGI) Upgraded; (RL) (DG) (ROK) Downgraded
Oct 29, 2015 09:04AM Roth Capital Reiterates Buy on Ellie Mae (ELLI) Following 3Q Results
View More Recent Stories View Older Stories